Treatment of triple negative breast cancer and impact on patient survival
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://onco.news/index.php/journal/article/view/54 |
Resumo: | Describe the therapeutic options available and analyze the life expectancy of women diagnosed with triple-negative breast cancer. This was a systematic literature review, the search platforms LILACS, BVS, PubMed and Periódicos capes were used to find articles published from 2015 to 2021 in Portuguese, English and Spanish languages. The keywords "triple negative breast cancer" and "life expectancy" were applied, using the Boolean operator AND. In the end 14 studies were selected that fit the inclusion criteria. Triple-negative breast cancer has limited therapeutic options due to its immunohistochemical classification, thus being constantly subjected to chemotherapy, radiotherapy and surgical procedures that leave the patient weakened. However, other methodologies such as immunotherapy and the use of drugs with different therapeutic targets are under development, preliminary results show an increase in patient survival and the possibility of a promising future in the therapy of triple negative tumor. |
id |
RCAP_c71b4a5a373068b4dc6123168c4d7e5e |
---|---|
oai_identifier_str |
oai:oai.onco.news:article/54 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Treatment of triple negative breast cancer and impact on patient survivalTratamento do câncer de mama triplo negativo e impacto na sobrevida das pacientesNeoplasia triplo-negativaAntineoplásicosImunohistoquímicaTriple-negative neoplasiaAntineoplasticsImmunohistochemistryDescribe the therapeutic options available and analyze the life expectancy of women diagnosed with triple-negative breast cancer. This was a systematic literature review, the search platforms LILACS, BVS, PubMed and Periódicos capes were used to find articles published from 2015 to 2021 in Portuguese, English and Spanish languages. The keywords "triple negative breast cancer" and "life expectancy" were applied, using the Boolean operator AND. In the end 14 studies were selected that fit the inclusion criteria. Triple-negative breast cancer has limited therapeutic options due to its immunohistochemical classification, thus being constantly subjected to chemotherapy, radiotherapy and surgical procedures that leave the patient weakened. However, other methodologies such as immunotherapy and the use of drugs with different therapeutic targets are under development, preliminary results show an increase in patient survival and the possibility of a promising future in the therapy of triple negative tumor.Descrever as opções terapêuticas disponíveis e analisar a expectativa de vida de mulheres diagnosticadas com câncer de mama triplo-negativo. Tratou-se de uma revisão sistemática de literatura, foram utilizadas as plataformas de pesquisa LILACS, BVS, PubMed e Periódicos capes para encontrar artigos publicados de 2015 à 2021 nos idiomas português, inglês e espanhol. Foram aplicadas as palavras-chave “câncer de mama triplo negativo” e “expectativa de vida”, utilizando o operador booleano E (AND). Ao final foram selecionados 14 estudos que se adequavam nos critérios de inclusão. O câncer de mama triplo-negativo apresenta limitadas opções terapêuticas devido sua classificação imuno-histoquímica, sendo assim submetido constantemente a quimioterapia, radioterapia e procedimento cirúrgico que deixam a paciente fragilizada. Entretanto, outras metodologias como a imunoterapia e uso de fármacos com diferentes alvos terapêuticos estão em desenvolvimento, resultados preliminares demonstram um aumento na sobrevida das pacientes e possibilidade de um futuro promissor na terapia do tumor triplo negativo.AEOP – Associação de Enfermagem Oncológica Portuguesa2022-11-09info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://onco.news/index.php/journal/article/view/54Onco.news; No. 45 (2022): Onco.News Journal (july-december); e054Onco.News; N.º 45 (2022): Revista Onco.News (julho-dezembro); e0542183-69141646-7868reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://onco.news/index.php/journal/article/view/54https://onco.news/index.php/journal/article/view/54/108Direitos de Autor (c) 2022 Ana Victória Mota Lima, Wenderson Pinheiro de Limainfo:eu-repo/semantics/openAccessVictória Mota Lima, AnaPinheiro de Lima, Wenderson2024-03-16T07:55:13Zoai:oai.onco.news:article/54Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T04:01:20.227203Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Treatment of triple negative breast cancer and impact on patient survival Tratamento do câncer de mama triplo negativo e impacto na sobrevida das pacientes |
title |
Treatment of triple negative breast cancer and impact on patient survival |
spellingShingle |
Treatment of triple negative breast cancer and impact on patient survival Victória Mota Lima, Ana Neoplasia triplo-negativa Antineoplásicos Imunohistoquímica Triple-negative neoplasia Antineoplastics Immunohistochemistry |
title_short |
Treatment of triple negative breast cancer and impact on patient survival |
title_full |
Treatment of triple negative breast cancer and impact on patient survival |
title_fullStr |
Treatment of triple negative breast cancer and impact on patient survival |
title_full_unstemmed |
Treatment of triple negative breast cancer and impact on patient survival |
title_sort |
Treatment of triple negative breast cancer and impact on patient survival |
author |
Victória Mota Lima, Ana |
author_facet |
Victória Mota Lima, Ana Pinheiro de Lima, Wenderson |
author_role |
author |
author2 |
Pinheiro de Lima, Wenderson |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Victória Mota Lima, Ana Pinheiro de Lima, Wenderson |
dc.subject.por.fl_str_mv |
Neoplasia triplo-negativa Antineoplásicos Imunohistoquímica Triple-negative neoplasia Antineoplastics Immunohistochemistry |
topic |
Neoplasia triplo-negativa Antineoplásicos Imunohistoquímica Triple-negative neoplasia Antineoplastics Immunohistochemistry |
description |
Describe the therapeutic options available and analyze the life expectancy of women diagnosed with triple-negative breast cancer. This was a systematic literature review, the search platforms LILACS, BVS, PubMed and Periódicos capes were used to find articles published from 2015 to 2021 in Portuguese, English and Spanish languages. The keywords "triple negative breast cancer" and "life expectancy" were applied, using the Boolean operator AND. In the end 14 studies were selected that fit the inclusion criteria. Triple-negative breast cancer has limited therapeutic options due to its immunohistochemical classification, thus being constantly subjected to chemotherapy, radiotherapy and surgical procedures that leave the patient weakened. However, other methodologies such as immunotherapy and the use of drugs with different therapeutic targets are under development, preliminary results show an increase in patient survival and the possibility of a promising future in the therapy of triple negative tumor. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-11-09 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://onco.news/index.php/journal/article/view/54 |
url |
https://onco.news/index.php/journal/article/view/54 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://onco.news/index.php/journal/article/view/54 https://onco.news/index.php/journal/article/view/54/108 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2022 Ana Victória Mota Lima, Wenderson Pinheiro de Lima info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2022 Ana Victória Mota Lima, Wenderson Pinheiro de Lima |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
AEOP – Associação de Enfermagem Oncológica Portuguesa |
publisher.none.fl_str_mv |
AEOP – Associação de Enfermagem Oncológica Portuguesa |
dc.source.none.fl_str_mv |
Onco.news; No. 45 (2022): Onco.News Journal (july-december); e054 Onco.News; N.º 45 (2022): Revista Onco.News (julho-dezembro); e054 2183-6914 1646-7868 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138187190206464 |